MiNK Therapeutics Inc. (INKT)
0.86
0.01 (1.18%)
At close: Jan 15, 2025, 3:59 PM
0.87
0.60%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | 2.70B | n/a | n/a | 689.63K |
| Cost of Revenue | 204.62K | 30.95B | 28.36B | 55.06K | n/a |
| Gross Profit | -204.62K | -28.24B | -28.36B | -55.06K | 689.63K |
| Operating Income | -22.92M | -30.95M | -28.36M | -14.64M | -22.28M |
| Interest Income | 463.26K | 253.32K | 2.43K | 2.44K | 1.56K |
| Pretax Income | -22.46M | -27.99M | -30.21M | -16.24M | -23.80M |
| Net Income | -22.46M | -24.78M | -23.11M | -15.68M | -25.91M |
| Selling & General & Admin | 7.43M | 7.83M | 4.64M | 1.29M | 3.83M |
| Research & Development | 15.49M | 23.12M | 13.97M | 9.51M | 19.65M |
| Other Expenses | n/a | 2.70M | -9.53M | -3.00M | 551.24K |
| Operating Expenses | 22.92M | 30.95M | 18.61M | 10.80M | 23.48M |
| Interest Expense | n/a | 253.32K | 2.43M | 2.44M | 1.56M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 22.92M | 30.95M | 18.61M | 10.80M | 23.48M |
| Income Tax | n/a | -3.21M | -7.10M | -560.38K | 2.11M |
| Shares Outstanding (Basic) | 34.36M | 33.67M | 33.48M | 33.09M | 33.09M |
| Shares Outstanding (Diluted) | 34.36M | 33.67M | 33.48M | 33.09M | 33.09M |
| EPS (Basic) | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
| EPS (Diluted) | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
| EBITDA | -22.25M | -30.83M | -27.70M | -13.74M | -22.20M |
| Depreciation & Amortization | 204.62K | 121.75K | 77.96K | 55.06K | 36.82K |